WAPNICK PAMELA (Chief Financial Officer) sold 0.9% of their position (1.91K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/10/2026ACC: 0001193125-26-387786
Officer· Chief Financial Officer
Since Mar 2026
-1.91K
Net shares
Net seller
$2.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.91K
Price / share
$1.16
Trade value
$2.21K
% of position
0.9%
9/8/2026
208.49K→206.58K
Total
Net shares
−1.91K
Net value
-$2.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2026 | S · Sale | −1.91K | $1.16 | $2.21K | 0.9% | 208.49K | 206.58K |
| Total | −1.91K | -$2.21K | ||||||
Derivative Transactions0
No derivative transactions reported